Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
symbols : LLY save search
Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.9%
H: 0.78%
C: -2.73%
INCY | News | $75.64 -2.22% 0.93% |
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
ibi362 communications chinese diabetes results
Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
Published: 2022-06-29 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
| Email alert
Add to watchlist
INCY | News | $75.64 -2.22% 0.93% |
|
Health Technology
| Email alert
Add to watchlist
ibi362 communications chinese diabetes results
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
Published: 2022-06-28 (Crawled : 12:20) - globenewswire.com
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.9%
H: 0.78%
C: -2.73%
AKYA | News | $12.61 4.73% 1.83% |
|
Professional, Scientific, and T...
|
| O: 7.52%
H: 4.77%
C: 3.37%
oncosignature for test diagnostic therapeutics
DTx Pharma Appoints Peter Condon as Chief Business Officer
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.9%
H: 0.78%
C: -2.73%
pharma
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
ICLR | News | $219.14 -0.79% 0.0% |
|
Health Technology
|
| O: 1.05%
H: 0.96%
C: -0.24%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.9%
H: 0.78%
C: -2.73%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -2.98%
H: 0.66%
C: -0.87%
trials research technology
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.27%
H: 0.06%
C: -0.82%
ABBV | News | $152.49 -0.42% 0.0% |
|
Health Technology
|
| O: 0.06%
H: 1.27%
C: -0.44%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.9%
H: 0.78%
C: -2.73%
pharma
Lilly Declares Third-Quarter 2022 Dividend
Published: 2022-06-27 (Crawled : 21:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
AZNCF | $127.2501 |
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | $84.17 -1.3% 0.17% |
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | $43.35 -0.8% 0.19% |
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
GLAXF | $21.99 |
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
PFE | News | $50.66 -2.35% 0.4% |
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
SPPI A | $0.8436 -1.91% 1.74% |
|
Health Technology
|
| O: 0.0%
H: 2.28%
C: -2.27%
SNYNF | News | $108.84 |
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
BMY | $78.7 -1.6% 0.38% |
|
Health Technology
|
| O: 0.78%
H: 1.72%
C: 0.95%
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
AZN | $65.94 -0.86% 0.21% |
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
immunotherapy report therapy cancer market
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2022-06-27 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
INCY | News | $75.64 -2.22% 0.93% |
|
Health Technology
|
| O: 3.36%
H: 0.35%
C: -0.71%
tyvyt treatment approval china
AC Immune Holds Annual General Meeting of Shareholders
Published: 2022-06-24 (Crawled : 21:00) - globenewswire.com
ACIU | $3.9 15.04% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
| Email alert
Add to watchlist
meeting
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: 2022-06-24 (Crawled : 21:00) - globenewswire.com
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
| Email alert
Add to watchlist
VERU | $11.81 -8.17% -0.23% |
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants
Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published: 2022-06-24 (Crawled : 12:00) - prnewswire.com
AZN | $65.94 -0.86% 0.21% |
|
Health Technology
|
| O: 4.41%
H: 0.0%
C: 0.0%
JNJ | News | $176.94 -2.84% 0.18% |
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: 0.0%
PFE | News | $50.66 -2.35% 0.4% |
|
Health Technology
|
| O: 2.96%
H: 0.0%
C: 0.0%
AZNCF | $127.2501 |
|
Health Technology
|
| O: 0.64%
H: 4.18%
C: 1.33%
NVS | $84.17 -1.3% 0.17% |
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: 0.0%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 3.32%
H: 0.0%
C: 0.0%
treatment report psoriasis market
Ancora Heart Appoints Mark Miles as Chief Commercial Officer
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 4.14%
H: 0.0%
C: 0.0%
commercial heart miles
IconOVir Bio Appoints William Kaelin, Jr., M.D., to Board of Directors
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 4.14%
H: 0.0%
C: 0.0%
Orange Grove Bio Provides Corporate Update Highlighting Key Leadership Appointments and Establishment of New Academic Collaboration
Published: 2022-06-23 (Crawled : 12:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 4.14%
H: 0.0%
C: 0.0%
collaboration update
Novel T-Cell Immunotherapies Market - Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
Published: 2022-06-23 (Crawled : 08:00) - prnewswire.com
TAK | $13.86 -1.42% 0.0% |
|
Health Technology
|
| O: 1.56%
H: 0.73%
C: 0.44%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 4.14%
H: 0.0%
C: 0.0%
report t-cell trial market
Delfi Diagnostics Appoints Jacob Van Naarden to its Board of Directors
Published: 2022-06-22 (Crawled : 13:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: 0.0%
diagnostics
AVEO Oncology Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ERBITUX® (cetuximab) in North America to Evaluate Ficlatuzumab and Cetuximab in Patients with Recurrent or Metastatic HNSCC
Published: 2022-06-22 (Crawled : 12:00) - investor.aveooncology.com
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: 0.0%
AVEO | $6.36 -4.65% 0.0% |
|
Health Technology
|
| O: 8.59%
H: 9.93%
C: 5.88%
erbitux america for collaboration trial agreement
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma
Published: 2022-06-21 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
INCY | News | $75.64 -2.22% 0.93% |
|
Health Technology
|
| O: 5.74%
H: 0.0%
C: 0.0%
tyvyt treatment for approval china
The Worldwide Herpes Zoster Treatment Industry is Expected to Reach $303.4 Million by 2030
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
BHC A | $8.83 1.73% 0.11% |
|
Health Technology
| Email alert
Add to watchlist
PPRUY | News | $52.24 |
|
Manufacturing
| Email alert
Add to watchlist
ABT | News | $106.97 -1.93% -0.11% |
|
Health Technology
| Email alert
Add to watchlist
PPRUF | News | $534.0 |
|
Consumer Non-Durables
| Email alert
Add to watchlist
GSK | $43.35 -0.8% 0.19% |
|
Health Technology
| Email alert
Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $21.99 |
|
Health Technology
| Email alert
Add to watchlist
treatment expected
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ACN | News | $283.8 -3.01% 0.07% |
|
Technology Services
BTG | News | $3.56 -2.73% 0.84% |
|
Non-Energy Minerals
DELL | News | $48.94 -2.59% 0.0% |
|
Electronic Technology
GLPI | News 0 d | $46.68 -0.09% 0.0% |
|
Finance
INCY | News | $75.64 -2.22% 0.93% |
|
Health Technology
JTEKF | News | $ 0% |
|
Producer Manufacturing
JTEKY | News | $24.29 |
|
Manufacturing
LEA | News | $134.75 0.57% 0.0% |
|
Producer Manufacturing
LLY | News 4 | $317.62 -2.95% -0.03% |
|
Health Technology
NDAQ | News 4 | $154.64 -2.08% -0.23% |
|
Finance
PPRUF | News | $534.0 |
|
Consumer Non-Durables
PPRUY | News | $52.24 |
|
Manufacturing